Mavundza E, Jaca A, Cooper S, Ndwandwe D, Wiysonge C
BMJ Open. 2024; 14(11):e082592.
PMID: 39542479
PMC: 11575253.
DOI: 10.1136/bmjopen-2023-082592.
Wang W
Sci Rep. 2024; 14(1):20341.
PMID: 39242754
PMC: 11379873.
DOI: 10.1038/s41598-024-71494-0.
Cheema S, Abraham A, Maisonneuve P, Jithesh A, Chaabna K, Al Janahi R
BMC Public Health. 2024; 24(1):2316.
PMID: 39187821
PMC: 11348518.
DOI: 10.1186/s12889-024-19792-0.
Choi J, Gabay E, Cuccaro P
Vaccines (Basel). 2024; 12(4).
PMID: 38675743
PMC: 11053788.
DOI: 10.3390/vaccines12040361.
Zou K, Huang Y, Li Z
Front Cell Infect Microbiol. 2022; 12:1077651.
PMID: 36506029
PMC: 9729793.
DOI: 10.3389/fcimb.2022.1077651.
Human Papillomavirus Vaccination in Male University Students in Turkey: Coverage Rate, Barriers, and Associated Factors.
Gursoy M, Sagtas F
J Prev (2022). 2022; 44(2):181-191.
PMID: 36305982
PMC: 9615610.
DOI: 10.1007/s10935-022-00711-1.
Low awareness of HPV infection and willingness of HPV vaccination among Chinese male college students in the east of China.
Ran H, Chen Y, Gao J, Guo H, Peng S
Front Public Health. 2022; 10:971707.
PMID: 36203657
PMC: 9531242.
DOI: 10.3389/fpubh.2022.971707.
Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study.
Fu L, Tian T, Yao K, Chen X, Luo G, Gao Y
JMIR Public Health Surveill. 2022; 8(7):e34874.
PMID: 35793140
PMC: 9301560.
DOI: 10.2196/34874.
Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015-2019.
Li X, Xiang F, Chen Z, Zhang T, Zhu Z, Zhang M
Med Sci Monit. 2021; 27:e932093.
PMID: 34475371
PMC: 8422898.
DOI: 10.12659/MSM.932093.
Prevalence, Genotype Distribution, and Predictors against HPV Infections Targeted by 2-, 4-, 9-Valent HPV Vaccines among Japanese Males.
Matsuzawa Y, Kitamura T, Suzuki M, Koyama Y, Shigehara K
Vaccines (Basel). 2020; 8(2).
PMID: 32422939
PMC: 7349125.
DOI: 10.3390/vaccines8020221.
HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in....
Nicoli F, Mantelli B, Gallerani E, Telatin V, Bonazzi I, Marconi P
Vaccines (Basel). 2020; 8(1).
PMID: 31947611
PMC: 7175219.
DOI: 10.3390/vaccines8010026.
Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study.
Lazcano-Ponce E, Sudenga S, Torres B, Stoler M, Leon-Maldonado L, Allen-Leigh B
Salud Publica Mex. 2019; 60(6):633-644.
PMID: 30699268
PMC: 6642747.
DOI: 10.21149/8461.
Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
Harder T, Wichmann O, Klug S, van der Sande M, Wiese-Posselt M
BMC Med. 2018; 16(1):110.
PMID: 30016957
PMC: 6050686.
DOI: 10.1186/s12916-018-1098-3.
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.
Ruiz-Sternberg A, Moreira Jr E, Restrepo J, Lazcano-Ponce E, Cabello R, Silva A
Papillomavirus Res. 2017; 5:63-74.
PMID: 29269325
PMC: 5887018.
DOI: 10.1016/j.pvr.2017.12.004.
Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age.
Moreira E, Giuliano A, de Hoon J, Iversen O, Joura E, Restrepo J
Hum Vaccin Immunother. 2017; 14(2):396-403.
PMID: 29211620
PMC: 5806635.
DOI: 10.1080/21645515.2017.1403700.
Parents' views of including young boys in the Swedish national school-based HPV vaccination programme: a qualitative study.
Gottvall M, Stenhammar C, Grandahl M
BMJ Open. 2017; 7(2):e014255.
PMID: 28246143
PMC: 5337740.
DOI: 10.1136/bmjopen-2016-014255.
